Metabolic Interventions for Sleep, Anesthesia-related Neurocognitive Disorders and Alzheimer's Disease
针对睡眠、麻醉相关神经认知障碍和阿尔茨海默病的代谢干预
基本信息
- 批准号:10419578
- 负责人:
- 金额:$ 55.58万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-06-15 至 2027-02-28
- 项目状态:未结题
- 来源:
- 关键词:AcetoacetatesAcetylcholineAddressAdenosineAgeAgingAlzheimer&aposs DiseaseAlzheimer’s disease biomarkerAnesthesia proceduresAnestheticsAnimalsAntiinflammatory EffectAnxietyBiosensorBloodBrainBrain DiseasesCarbohydratesClinicalDementiaDietEatingElderlyElectroencephalographyEpilepsyExerciseFatty AcidsFatty acid glycerol estersGeneral AnesthesiaGeneral anesthetic drugsGlioblastomaGlucoseGlutamatesImmuneImpaired cognitionInflammationInflammatoryInflammatory ResponseInsulin ResistanceInterleukin-1Interleukin-10Interleukin-17Interleukin-6InterventionKetone BodiesKetonesLeadLinkMeasuresMental DepressionMetabolicMethodsMicrodialysisMitochondriaNF-kappa BNeurodegenerative DisordersNeuromodulatorNeuronsNorepinephrineParkinson DiseasePathway interactionsPrefrontal CortexPropofolPurinergic P1 ReceptorsPyruvateREM SleepRattusReactive Oxygen SpeciesResearchRodentSafetySeizuresSignal TransductionSleepSleep FragmentationsSleep disturbancesSourceStarvationTestingTimeWeightagedaging brainaging populationantagonistautism spectrum disorderbeta-Hydroxybutyratebrain healthbrain metabolismearly detection biomarkersexperimental studygamma-Aminobutyric Acidimprovedinflammatory markerinnovationketogenic dietliquid chromatography mass spectrometrymetabolomicsmitochondrial dysfunctionneurocognitive disorderneuronal metabolismneurotransmitter releasenew therapeutic targetnon rapid eye movementnormal agingnovel strategiespoor sleeppost-operative cognitive dysfunctionpostoperative deliriumsevofluranesleep quality
项目摘要
ABSTRACT
This objective of this research is to develop metabolic interventions to improve sleep quality and
anesthesia safety in the elderly and eventually to treat neurodegenerative diseases like Alzheimer's disease.
The aging brain has many changes including mitochondrial dysfunction, insulin resistance and decreased
neurotransmitter release leading to poor sleep quality and more complications with general anesthesia. The
ability of the brain to use glucose declines with age but the brain's ability to use ketones as fuel remains. Ketone
bodies are produced naturally from the breakdown of fatty acids and become a major fuel source for the brain
during times of starvation, exercise and high-fat, low-carbohydrate diets. The ketone bodies acetoacetate and
beta-hydroxybutyrate not only provide energy to the brain but also have potent signaling and anti-inflammatory
effects. The activation of inflammatory pathways, such as nuclear factor kappa B, are thought to be one
mechanism through which sleep disturbance and dementia are linked as well as post-operative delirium and
post-operative cognitive dysfunction. The inflammatory response is also tightly correlated with the onset and
clinical course of Alzheimer's disease and disruptions in sleep are an early biomarker of Alzheimer's disease.
Sleep quality declines with normal age as well, losing restorative slow and delta power and becoming more
fragmented. Therefore, targeting brain energy usage by providing ketones could be one strategy for improving
sleep quality in aged animals. In addition, the aged population is more susceptible to general anesthesia. Less
anesthesia is needed to anesthetize older people and they are more likely to develop post-operative cognitive
dysfunction. The energy substrate and anti-inflammatory effects of ketones could be neuroprotective during
anesthesia in the aged brain. Taken together, these ideas give rise to novel strategies that address the
dysfunctional neuronal metabolic-immune interactions in the aged brain by increasing ketones that could lead to
improved sleep quality (AIM 1) and safer delivery of general anesthesia (AIM 2) to the elderly. These innovative
strategies to improve brain health in the aged population have the potential for broad impact as many brain
diseases have components of metabolic dysregulation including epilepsy, Alzheimer's disease, Parkinson's
disease, autism, anxiety, depression and glioblastoma.
抽象的
本研究的目的是开发代谢干预措施以改善睡眠质量和
老年人的麻醉安全,并最终治疗阿尔茨海默病等神经退行性疾病。
衰老的大脑会出现许多变化,包括线粒体功能障碍、胰岛素抵抗和功能下降。
神经递质释放导致睡眠质量差和全身麻醉出现更多并发症。这
大脑使用葡萄糖的能力随着年龄的增长而下降,但大脑使用酮作为燃料的能力仍然存在。酮
身体由脂肪酸分解自然产生,并成为大脑的主要燃料来源
在饥饿、运动和高脂肪、低碳水化合物饮食期间。酮体乙酰乙酸和
β-羟基丁酸不仅为大脑提供能量,还具有有效的信号传导和抗炎作用
影响。炎症途径的激活,例如核因子 kappa B,被认为是其中之一
睡眠障碍与痴呆以及术后谵妄之间的联系机制
术后认知功能障碍。炎症反应也与发病和发生密切相关。
阿尔茨海默病的临床病程和睡眠中断是阿尔茨海默病的早期生物标志物。
睡眠质量也会随着正常年龄的增长而下降,失去恢复性的慢速能量和增量能量,并且变得更加严重。
支离破碎。因此,通过提供酮来瞄准大脑能量的使用可能是改善大脑能量使用的一种策略。
老年动物的睡眠质量。此外,老年人口更容易受到全身麻醉的影响。较少的
老年人需要麻醉,他们更有可能出现术后认知能力
功能障碍。酮的能量底物和抗炎作用可能在神经保护过程中发挥作用
老年大脑的麻醉。总而言之,这些想法产生了解决以下问题的新颖策略:
通过增加酮体,老年大脑中功能失调的神经元代谢-免疫相互作用可能导致
改善老年人的睡眠质量 (AIM 1) 并更安全地实施全身麻醉 (AIM 2)。这些创新的
改善老年人脑健康的策略有可能产生广泛影响,因为许多大脑
具有代谢失调成分的疾病包括癫痫、阿尔茨海默病、帕金森病
疾病、自闭症、焦虑、抑郁和胶质母细胞瘤。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Christa Joy Nehs其他文献
Christa Joy Nehs的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Christa Joy Nehs', 18)}}的其他基金
Metabolic Interventions for Sleep, Anesthesia-related Neurocognitive Disorders and Alzheimer's Disease
针对睡眠、麻醉相关神经认知障碍和阿尔茨海默病的代谢干预
- 批准号:
10633125 - 财政年份:2022
- 资助金额:
$ 55.58万 - 项目类别:
相似国自然基金
基于芋螺毒素肽RgIA的α9α10烟碱型乙酰胆碱受体降解剂用于神经性疼痛治疗
- 批准号:22307083
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
乙酰胆碱-巨噬细胞神经免疫轴在肿瘤运动康复中的作用及机制研究
- 批准号:82303930
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
烟碱型乙酰胆碱受体变异介导普通大蓟马对多杀菌素抗性机制研究
- 批准号:32360663
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
神经肽Y-Y1受体与α7烟碱型乙酰胆碱受体交互作用减轻急性肺损伤的机制研究
- 批准号:82300019
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
慢性应激诱导肺上皮分泌乙酰胆碱重塑乳腺癌肺转移前微环境的机制研究
- 批准号:82303386
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
CRCNS: Role of mAChRs on CA 1 pyramidal neurons in memory formation and stability
CRCNS:mAChR 对 CA 1 锥体神经元在记忆形成和稳定性中的作用
- 批准号:
10831251 - 财政年份:2023
- 资助金额:
$ 55.58万 - 项目类别:
Human-iPSC derived neuromuscular junctions as a model for neuromuscular diseases.
人 iPSC 衍生的神经肌肉接头作为神经肌肉疾病的模型。
- 批准号:
10727888 - 财政年份:2023
- 资助金额:
$ 55.58万 - 项目类别:
The effect of aging on neurotransmitters and motor performance in a primate model
衰老对灵长类动物模型中神经递质和运动表现的影响
- 批准号:
10573386 - 财政年份:2023
- 资助金额:
$ 55.58万 - 项目类别:
Genetic and molecular mechanisms of Xbp-1 mediated salivary gland development and differentiation
Xbp-1介导唾液腺发育和分化的遗传和分子机制
- 批准号:
10678146 - 财政年份:2023
- 资助金额:
$ 55.58万 - 项目类别:
The role of oxidative stress in reduced microvascular function after gestational diabetes
氧化应激在妊娠糖尿病后微血管功能下降中的作用
- 批准号:
10712433 - 财政年份:2023
- 资助金额:
$ 55.58万 - 项目类别: